Providing market intelligence for more than 35 years

In The News

The Apple Watch Has Gotten Simpler, But That’s OK

Apple’s decision to simplify the watch speaks to a larger issue facing makers of wearables: Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.

“I don’t think Apple wants to be a health-monitoring device maker,” said Harry Wang, director of health and mobile product research at Parks Associates. “They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.”

That information is being gathered through Apple’s new Health app, a dashboard of users’ health data, and HealthKit, a developer tool that lets wellness apps share data. The watch could be populated with messages from external devices and services that track specialized health information.

From the article "The Apple Watch Has Gotten Simpler, But That’s OK" by Stephanie M. Lee.

Previously In The News

Netflix Beware, Hulu Is the Dark Horse That Will Take Over 2016

On the other hand, achieving such a feat may not be as easy it seems. Data published by Parks Associates highlights that during the past 12 months, approximately 50% of Hulu’s subscribers have not opt...

Revenge of the Antenna

The percentage of broadband-connected households using antenna-delivered broadcast TV has jumped from 9 percent to 15 percent over the past three years. And the percentage getting pay-TV service has d...

PayPal Leads The Way In US Mobile Payments, But Retailers Not Happy

Mobile payments are still an up-and-coming new capability for consumers; while mobile banking has clearly led the way, there’s still a lot of interest in mobile payments at least in some fields. Wh...

TTA’s Week: Digital Health Funding, Execs’ Wish List, ActivePreventive Responds…And Theranos

We compare two major analyses of 2016 digital health funding, note a tender opportunity and an award in UK, and two more chapters of the Theranos Story. The ActiveProtective CEO responds to Reader and...